Adenosine Monophosphate for Injection
Function and Efficacy
Generally, when the dosage is lower than 10 mg per kg of body weight per day, the side effects are mild or not obvious. When the dosage exceeds 10 mg per kg of body weight per day, loss of appetite, dizziness, tinnitus, general fatigue, nausea, etc. may be seen. The causal relationship between the above reactions and the treatment itself has not yet been determined.
Ingredients
Main ingredient: Adenosine monophosphate
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Vidarabine monophosphateIngredients |
Generally, when the dosage is lower than 10 mg per kg of body weight per day, the side effects are mild or not obvious. When the dosage exceeds 10 mg per kg of body weight per day, loss of appetite, dizziness, tinnitus, general fatigue, nausea, etc. may be seen. The causal relationship between the above reactions and the treatment itself has not yet been determined. More |
29984-33-6 | 12 |
Indication
Used to treat stomatitis, dermatitis, encephalitis and cytomegalovirus infection caused by herpes virus infection.
Usage and Dosage
Before use, add 2 ml of sterile saline to each bottle and dissolve it, then inject it intramuscularly or slowly intravenously, or follow the doctor's advice. For adults, take 5-10 mg/kg per day according to body weight. Pay close attention to the occurrence of adverse reactions during medication and deal with them in time.
Adverse Reactions
Pain at the injection site may be seen. In rare cases, neuromuscular pain and joint pain may occur, and thrombocytopenia, leukopenia or bone marrow giant cell hyperplasia may occasionally occur, which can recover on their own after discontinuation of the drug and are reversible. Symptomatic treatment can be used if necessary. The degree of adverse reactions is positively correlated with the dosage and course of treatment.
Drug Interactions
Pain at the injection site may be seen. In rare cases, neuromuscular pain and joint pain may occur, and thrombocytopenia, leukopenia or bone marrow giant cell hyperplasia may occasionally occur, which can recover on their own after discontinuation of the drug and are reversible. Symptomatic treatment can be used if necessary. The degree of adverse reactions is positively correlated with the dosage and course of treatment.
Storage
Keep away from light, tightly closed and in a dry place.
Packaging Specification
0.2g
Manufacturer
Sinopharm A-Think Pharmaceutical Co., Ltd.
-
Founded in:
1997-12-10 -
Address:
No. 111, Yixin Road, Shuangyang Economic Development Zone, Changchun -
Tax NO.:
912201012440638092 -
Registered Funds:
100 million yuan -
Website:
-
Email: